help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2007-0123
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fricker, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fricker, L. D.
Endocrinology Vol. 148, No. 9 4185-4190
Copyright © 2007 by The Endocrine Society

Neuropeptidomics to Study Peptide Processing in Animal Models of Obesity

Lloyd D. Fricker

Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461

Address all correspondence and requests for reprints to: Lloyd Fricker, Ph.D., Professor, Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461. E-mail: fricker{at}aecom.yu.edu.

Neuropeptidomics is the analysis of the neuropeptides present in a tissue extract. Most neuropeptidomic studies use mass spectrometry to detect and identify the peptides, which provides information on the precise posttranslationally modified form of each peptide. Quantitative peptidomics uses isotopic labels to compare the levels of peptides in extracts from two different samples. This technique is ideal for examining neuropeptide levels in a variety of systems and is especially suited for studies of mice lacking peptide-processing enzymes. This review is focused on the neuropeptidomics technique and its application to the analysis of mice with a mutation that inactivates carboxypeptidase E, a critical enzyme in the biosynthesis of many neuroendocrine peptides. Mice without carboxypeptidase E activity are overweight, and a key question is the identification of the peptide or peptides responsible. The quantitative peptidomics approach has provided some insights toward the answer to this question.




This article has been cited by other articles:


Home page
FASEB J.Home page
I. Gomes, J. S. Grushko, U. Golebiewska, S. Hoogendoorn, A. Gupta, A. S. Heimann, E. S. Ferro, S. Scarlata, L. D. Fricker, and L. A. Devi
Novel endogenous peptide agonists of cannabinoid receptors
FASEB J, September 1, 2009; 23(9): 3020 - 3029.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Romero, I. Cakir, C. A. Vaslet, R. C. Stuart, O. Lansari, H. A. Lucero, and E. A. Nillni
Role of a Pro-sequence in the Secretory Pathway of Prothyrotropin-releasing Hormone
J. Biol. Chem., November 14, 2008; 283(46): 31438 - 31448.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. Lyons, M. B. Callaway, and L. D. Fricker
Characterization of Carboxypeptidase A6, an Extracellular Matrix Peptidase
J. Biol. Chem., March 14, 2008; 283(11): 7054 - 7063.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society